"Hyperbilirubinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.
| Descriptor ID |
D006932
|
| MeSH Number(s) |
C23.550.429
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperbilirubinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperbilirubinemia".
This graph shows the total number of publications written about "Hyperbilirubinemia" by people in this website by year, and whether "Hyperbilirubinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 1 | 3 |
| 2018 | 5 | 1 | 6 |
| 2019 | 3 | 2 | 5 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperbilirubinemia" by people in Profiles.
-
The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities. Eur J Gastroenterol Hepatol. 2021 12 01; 33(1S Suppl 1):e274-e281.
-
Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes. JAMA. 2021 05 25; 325(20):2076-2086.
-
An unusual cause of fever and jaundice. Indian J Med Microbiol. 2021 07; 39(3):320-322.
-
Hepatic Involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran. Infect Disord Drug Targets. 2021; 21(8):e160921191569.
-
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell. 2020 10; 11(10):771-775.
-
Jaundice in a patient treated with Anakinra in a context of Covid-19. Infect Dis Now. 2021 Mar; 51(2):217-218.
-
Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19. Ann Hematol. 2021 Mar; 100(3):833-835.
-
Are icteric and lipemic indices reliable to screen for hyperbilirubinemia and hypertriglyceridemia? Clin Chem Lab Med. 2019 12 18; 58(1):e1-e4.
-
Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma. Clin Chem Lab Med. 2019 Oct 25; 57(11):1784-1789.
-
Contributing factors and outcomes of burn-associated cholestasis. J Hepatol. 2019 09; 71(3):563-572.